Quercetin improves the protection of hydroxysafflor yellow a against cerebral ischemic injury by modulating of blood-brain barrier and src-p-gp-mmp-9 signalling
Xiang Li,
Yuanxiao Yang,
Pinpin Feng,
Hongwei Wang,
Mingzhi Zheng,
Yiliang Zhu,
Kai Zhong,
Jue Hu,
Yilu Ye,
Linhuizi Lu,
Qinqin Zhao
Affiliations
Xiang Li
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Yuanxiao Yang
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Pinpin Feng
Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China
Hongwei Wang
Department of Anesthesiology, Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China
Mingzhi Zheng
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Yiliang Zhu
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Kai Zhong
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Jue Hu
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Yilu Ye
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Linhuizi Lu
Department of Clinical Medicine, Hangzhou Medical College, Hangzhou, 311399, China
Qinqin Zhao
Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China; Corresponding author.
Protection of the structural and functional integrity of the blood-brain barrier (BBB) is crucial for treating ischemic stroke (IS). Hydroxysafflor yellow A (HSYA) and quercetin (Quer), two main active components in the edible and medicinal plant Carthamus tinctorius L., have been reported to exhibit neuroprotective effects. We investigated the anti-IS and BBB-protective properties of HSYA and Quer and the underlying mechanisms. They decreased neurological deficits in middle cerebral artery occlusion (MCAO) mice, while their combination showed better effects. Importantly, HSYA and Quer ameliorated BBB permeability. Their effects on reduction of both EB leakage and infarct volume were similar, which may contribute to improved locomotor activities. Moreover, HSYA and Quer showed protective effects for hCMEC/D3 monolayer against oxygen-glucose deprivation. Src, p-Src, MMP-9, and P-gp were associated with ingredients treatments. Furthermore, molecular docking and molecular dynamics simulations revealed stable and tight binding modes of ingredients with Src and P-gp. The current study supports the potential role of HSYA, Quer, and their combination in the treatment of IS by regulating BBB integrity.